PolednakA.P.. Estimating the prevalence of cancer in the United States.Cancer.1997; 80: 136–141.
2.
HewittM., BreenN., DevesaS.. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey.J Natl Cancer Inst.1999; 91: 1480–1486.
3.
HodgsonT.A.. The state of the art of cost-of-illness-estimates.Adv Health Econ Health Serv Res.1983; 4: 129–164.
4.
BakerM.S., KesslerL.G., UrbanN.. Estimating the treatment costs of breast and lung cancer.Med Care.1991; 29: 40–49.
5.
TorranceG.W.. Measurement of health state utilities for economic appraisal: a review.J Health Econ.1986; 5: 1–30.
6.
ChirikosT.N.. Aggregate economic losses from disability in the United States: a preliminary assay.Milbank Q.1989; 67(suppl 2, pt 1): 59–91.
7.
SchuetteH.L., TuckerT.C., BrownM.L.. The costs of cancer care in the United States: implications for action.Oncology (Huntingt).1995; 9(11 suppl): 19–22.
8.
BrownM.L., FintorL.. The economic burden of cancer. In: GreenwaldP., KramerB.S., WeedD.L., eds. Cancer Prevention and Control.New York, NY: Marcel Dekker;1995: 69–81.
9.
HartunianN.S., SmartC.N., ThompsonM.S.. The Incidence of Economic Costs of Major Health Impairments: A Comparative Analysis of Cancer, Motor Vehicle Injuries, Coronary Heart Disease, and Stroke.Lexington, Mass: Lexington Books; 1981.
10.
ScitovskyA.A., McCallN.. Economic impact of breast cancer.Front Radiat Ther Oncol.1978; 11: 90–101.
11.
McKean-CowdinR., FeigelsonH.S., RossR.K.. Declining cancer rates in the 1990s.J Clin Oncol.2000; 18: 2258–2268.
12.
WingoP.A., RiesL.A.G., RosenbergH.M.. Cancer incidence and mortality, 1973-1995: a report card for U.S. cancer.Cancer.1998; 82: 1197–1207.
13.
ChuK.C., TaroneR.E., KesslerL.G.. Recent trends in U.S. breast cancer incidence, survival, and mortality rates.J Natl Cancer Inst.1996; 88: 1571–1579.
14.
WinchesterD.P., OsteenR.T., MenckH.R.. The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age.Cancer.1996; 78: 1838–1843.
15.
KesslerL.G.. The relationship between age and incidence of breast cancer. Population and screening program data.Cancer.1992; 69(7 suppl): 1896–1903.
16.
FeuerE.J., WunL.M., BoringC.C.. The lifetime risk of developing breast cancer.J Natl Cancer Inst.1993; 85: 892–897.
17.
ChirikosT.N.. The relationship between health and labor market status.Annu Rev Publ Health.1993; 14: 293–312.
18.
SatarianoW.A., RaglandD.R.. Upper-body strength and breast cancer: a comparison of the effects of age and disease.J Gerontol A Biol Sci Med Sci.1996; 51: M215–M219.
19.
Petrek JA HeelanM.C.. Incidence of breast carcinoma-related lymphedema.Cancer.1998; 83(12 suppl): 2776–2781.
20.
CarterB.J.. Women's experiences of lymphedema.Oncol Nurs Forum.1997; 24: 875–882.
21.
WeitznerM.A., MeyersC.A., StuebingK.K.. Relationship between quality of life and mood in long-term survivors of breast cancer treated with mastectomy.Support Care Cancer.1997; 5: 241–248.
22.
SatarianoW.A., DeLorenzeG.N.. The likelihood of returning to work after breast cancer.Public Health Rep.1996; 111: 236–241.
23.
FeldmanF.L.. Female cancer patients and caregivers: experiences in the workplace.Women & Health.1987; 12: 137–153.
24.
BursteinH.J., WinerE.P.. Primary care for survivors of breast cancer.N Engl J Med.2000; 343: 1086–1094.
25.
HoffmanB.. Cancer survivors’ employment and insurance rights: a primer for oncologists.Oncology (Huntingt).1999; 13: 841–846, 849, 852.
26.
RothsteinM.A., KennedyK., RitchieK.S.. Are cancer patients subject to employment discrimination?Oncology.1995; 9: 1303–1306, 1311-1312, 1315.
27.
Ehrmann-FeldmanD.. Perceived discrimination against cured cancer patients in the work force.Can Med Assoc J.1987; 136: 719–723.
28.
StommelM., GivenC.W., GivenB.A.. The cost of cancer home care to families.Cancer.1993; 71: 1867–1874.
29.
GivenB.A., GivenC.W., StommelM.. Family and out-of-pocket costs for women with breast cancer.Cancer Pract.1994; 2: 187–193.
30.
MooreK.A.. Breast cancer patients’ out-of-pocket expenses.Cancer Nurs.1999; 22: 389–396.